Simplex Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-53,301
Closed -$6.17M 10304
2023
Q3
$6.17M Sell
53,301
-21,662
-29% -$2.33M ﹤0.01% 1203
2023
Q2
$7.71M Buy
74,963
+44,457
+146% +$4.69M 0.01% 1052
2023
Q1
$3.33M Sell
30,506
-8,287
-21% -$916K ﹤0.01% 1547
2022
Q4
$4.41M Buy
+38,793
New +$3.22M ﹤0.01% 1294
2022
Q3
Sell
-36,280
Closed -$2.53M 11538
2022
Q2
$2.89M Buy
+36,280
New +$3.44M ﹤0.01% 1536
2022
Q1
Sell
-21,935
Closed -$2.14M 11993
2021
Q4
$2.36M Buy
21,935
+3,166
+17% +$345K ﹤0.01% 1867
2021
Q3
$1.81M Sell
18,769
-930
-5% -$96.5K ﹤0.01% 2281
2021
Q2
$1.84M Sell
19,699
-28,983
-60% -$2.67M ﹤0.01% 2275
2021
Q1
$0 Sell
48,682
-8,694
-15% -$734K ﹤0.01% 10631
2020
Q4
$4.2M Buy
57,376
+41,925
+271% +$3.12M 0.01% 1116
2020
Q3
$1.2M Buy
+15,451
New +$1.06M ﹤0.01% 2024
2019
Q4
Sell
-2,107
Closed -$64.6K 8463
2019
Q3
$57K Sell
2,107
-2,263
-52% -$58.5K ﹤0.01% 4900
2019
Q2
$105K Sell
4,370
-2,171
-33% -$55.1K ﹤0.01% 4142
2019
Q1
$172K Buy
6,541
+1,121
+21% +$26.6K ﹤0.01% 3775
2018
Q4
$105K Buy
5,420
+3,680
+211% +$72.1K ﹤0.01% 3821
2018
Q3
$34K Buy
+1,740
New +$33.1K ﹤0.01% 5537
2018
Q2
Sell
-12,300
Closed -$188K 8222
2018
Q1
$174K Buy
+12,300
New +$182K 0.01% 1337
2017
Q4
Sell
-42,718
Closed -$600K 7131
2017
Q3
$541K Buy
42,718
+17,341
+68% +$221K 0.02% 628
2017
Q2
$301K Buy
+25,377
New +$316K 0.01% 946
2016
Q4
Sell
-43,409
Closed -$787K 6922
2016
Q3
$787K Sell
43,409
-19,882
-31% -$388K 0.05% 334
2016
Q2
$1.04M Buy
+63,291
New +$1.02M 0.07% 264
2016
Q1
Sell
-79,959
Closed -$1.4M 6664
2015
Q4
$1.73M Buy
79,959
+65,620
+458% +$1.28M 0.14% 121
2015
Q3
$284K Buy
14,339
+12,306
+605% +$389K 0.02% 721
2015
Q2
$70K Buy
2,033
+1,983
+3,966% +$60.5K 0.01% 1433
2015
Q1
$1K Buy
+50
New +$917 ﹤0.01% 4721

Other funds holding HZNP

Simplex Trading's HZNP Position: Q4 2023 in Review

Simplex Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 53,301 shares — an estimated $6.17M sold.

Simplex Trading first reported a position in HZNP in Q1 2015 and held it in 25 quarters. The position peaked at $7.71M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Simplex Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 53,301 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.17M.
  • Simplex Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 25 quarters.
  • Simplex Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.71M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.